Back to funds

Foresite Capital Management IV, LLC

Updated 6 days ago

Managed by Foresite Capital Management Iv, Llc • Latest filing Q3 2026

Portfolio value
$252M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$229.7M
Q1 2026$237.1M
Q2 2026$290.2M
Q3 2026$252M

Top holdings

6 positions as of Q3 2026

View filing
P

Pharvaris N.V.

Value
$151.6M
Shares
4.78M
% Port
60.14%
C

CYTOKINETICS INC

Value
$47.1M
Shares
714.7K
% Port
18.69%
R

Relay Therapeutics, Inc.

Value
$22.6M
Shares
1.25M
% Port
8.95%
E

Eikon Therapeutics, Inc.

Value
$15.6M
Shares
1.94M
% Port
6.20%
V

VERACYTE, INC.

Value
$9.2M
Shares
200.0K
% Port
3.65%
X

Xenon Pharmaceuticals Inc.

Value
$6M
Shares
160.0K
% Port
2.36%

Explore